Plasma Biomarkers and Positron Emission Tomography Tau Pathology in Progressive Supranuclear Palsy
{{output}}
Background: Development of disease-modifying therapeutic trials of progressive supranuclear palsy (PSP) urges the need for sensitive fluid biomarkers. Objectives:... ...
